Beyond Air, Inc. cotiza a 2.19 USD y tiene una capitalización bursátil de $2M. En los últimos 12 meses ha facturado $8M con un margen de flujo de caja libre del -249.6%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Beyond Air, Inc. operates as a commercial-stage medical device and biopharmaceutical company. It operates through Beyond Air, Beyond Cancer, and NeuroNos segments. The company offers Lungfit PH for the treatment of persistent pulmonary hypertension of the newborn. It is also developing LungFit PRO to treat viral lung i…
| Periodo | 2026-11 | 2026-08 | 2026-06 | 2026-02 |
|---|---|---|---|---|
| Real | — | — | $-0.77 | $-0.85 |
| Estimado | $-8.40 | $-8.60 | $-0.57 | $-0.54 |
| Sorpresa | — | — | -35.1% | -57.4% |
| Métrica | XAIR | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 3.3% | 57.0% | -53.8% |
| Operating Margin | -378.2% | -38.6% | -339.6% |
| Net Margin | -433.0% | -33.6% | -399.4% |
| FCF Margin | -249.6% | -13.9% | -235.8% |
| ROE | -542.8% | -40.4% | -502.4% |
| ROA | -94.0% | -32.0% | -61.9% |
| Current Ratio | 3.80 | 2.84 | +0.96 |
| Debt / Equity | — | 0.28 | — |